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Background: The aim of this study was to evaluate the site, early results, and postoperative 
  complications of arteriovenous fistula (AVF) creation procedures for hemodialysis in 
our clinic.
Methods: The hospital records of 384 patients who underwent 411 AVF creation procedures 
for hemodialysis by the same team at our clinic between February 2008 and January 2010 
were included for retrospective analysis. All procedures were performed under local   anesthesia 
with lidocaine. Vasospasm was treated by mechanical dilatation with a probe and topical 
papaverine.
Results: Of our 384 patients, 58.5% were male and 41.5% were female. Mean age was 
46 (range 12–72) years. Of the 411 AVF procedures performed, 106 (25.8%) were created at 
the anatomical snuffbox, 264 (64.3%) were Brescia–Cimino procedures, and 41 (9.9%) were 
antecubital, brachiocephalic, or brachiobasilic procedures. Twenty-three patients (5.98%) were 
subjected to more than one surgical intervention due to early thrombosis or failure of AVF. Early 
patency was found in 94.0% of the AVF created. Twenty-three patients underwent more than 
one surgical intervention due to early AVF thrombosis or failure. Early AVF failure occurred 
more often in females (60.8%) than in males (39.2%). Complications were observed in a total 
of 11.4% patients.
Conclusion: Mechanical dilatation of the artery and vein, before starting the anastomosis, as 
well as the use of vasodilatory agents, could decrease early thrombosis of the fistula, and this 
method has very high early patency.
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Introduction
According to the US Renal Data System, the incidence of fistula in the US was 26.3% 
in 1998 and increased to 36.3% in 2003. Fistula prevalence also increased from 33% in 
2003 to 41% in 2005.1 Patients with end-stage renal failure need to receive hemodialysis 
through an effective arteriovenous fistula (AVF) until renal transplantation. Therefore, 
it is essential that the AVF has long-term patency.2 Quinton first used the external 
arteriovenous shunt in 1960, and Brescia–Cimino used the endogenous arteriovenous 
shunt in 1966.3,4 Vascular access that provides a minimum flow of 250 mL/dk is required 
for hemodialysis. AVFs are created to meet this requirement. For AVF creation, the 
veins of the patient need to be well preserved and not used previously.5,6 In patients 
with appropriate venous anatomy, all three types of AVF created on the upper extremity 
can supply adequate blood flow for hemodialysis.7 The radiocephalic Brescia–Cimino 
fistula created on the wrist is still the preferred AVF, although recently many surgeons Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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have been choosing to use the snuffbox AVF.5,7–10   However, 
the possibility of inadequate AVF patency remains a 
problem.11,12 The purpose of this study was to evaluate the 
site, early results, and postoperative complications of AVFs 
created for hemodialysis in our clinic.
Materials and methods
The hospital records of 384 patients who underwent 411 AVF 
procedures for hemodialysis by the same team at our clinic 
between February 2008 and January 2010 were included in this 
retrospective analysis. All patients were physically   evaluated, 
and the nondominant upper extremity was primarily chosen 
for AVF (ie, the left hand for right-handed patients and the 
right hand for left-handed patients). At the physical evaluation, 
arterial pulse strength, presence of a recent access, formation 
of a prominent elastic structure upon application of pressure, 
and vein diameters were assessed to determine the surgical 
site. For those patients who had more than one suitable site, 
the most distal one was generally selected in order to preserve 
the proximal site. Thrombosis formation within the first month 
was deemed “early”. Fistulae that were developed two or more 
times were considered to be “repetition”. All of the patients 
were followed up for the period starting from the creation of 
the AVF to the first hemodialysis.
surgical technique
Because the intention was to preserve the opportunity to 
move the AVF more proximally, the AVF was created on 
the nondominant arm as distally as possible. All surgical 
operations were performed under local anesthesia using 
lidocaine hydrochloride (Jetmonal®, Adeka, Istanbul,   Turkey). 
When creating the fistula, factors such as prominence of 
superficial veins, history of thrombophlebitis, segmental 
stenosis in the proximal vessel, atherosclerosis of the radial 
artery, and blood flow were considered. Following exploration 
of the arteries and veins and prior to placing the clamp, 
heparin (2 mL) was routinely administered intravenously 
to each patient. If necessary, hemostasis was subsequently 
facilitated by neutralization of heparin using protamine 
sulfate. The   end-to-side technique was preferred for distal 
anastomoses, and the side-to-side technique was preferred 
for proximal (antecubital) anastomoses. Vasospasm was 
treated by mechanical dilatation with a probe (1 mm, 1.5 mm, 
and 2 mm in diameter) and topical papaverine. For patients 
with inadequate venous flow, proximal dilatation was also 
performed using a Fogarty catheter. A continuous suture 
technique using 7/0 polypropylene was used to create the 
anastomoses.
statistical analysis
SPSS Windows statistical software package (v 10.0; Chicago, 
IL) was used for data analysis. Continuous variables are 
presented as means ± standard deviations. Student’s t-test, 
Chi-square test, and Fisher’s exact test were used. P , 0.05 
was accepted as being statistically significant.
Results
Of the 384 patients included in the study, 58.5% were 
male and 41.5% were female. The mean age was 46 
(range 12–72) years. Preoperative demographic data for the 
patients and causes of chronic renal failure are presented 
in Tables 1 and 2. Of 411 AVFs performed, 106 (25.8%) 
received a snuffbox AVF, 264 (64.3%) received a Brescia–
Cimino AVF, and 41 (9.9%) received an antecubital brachio-
cephalic, or brachiobasilic AVF (Table 3).
Early patency was found in 94.0% of the AVFs created. 
Most patients (320/384 [83.3%]) were undergoing their 
first AVF formation, whereas 64 patients (16.7%) had 
had at least one previous fistula. Surgical intervention 
was performed on the left upper extremity in 284 patients 
(64.5%) and on the right upper extremity in 126 patients 
(35.5%).
Seven patients (6.6%) had early failure of a snuffbox AVF 
and 17 (6.4%) had early failure of a Brescia–Cimino AVF. 
This difference was not statistically significant (P . 0.05). 
In total, 23 patients (5.9%) were subjected to more than 
one surgical intervention due to early AVF thrombosis 
and failure. AVFs were created three times in eight patients 
and two times in 11 patients. Thrombectomy was utilized 
successfully in four patients who presented with early failure. 
There were no early failures in patients who underwent 
brachiocephalic or brachiobasilic AVF formation. Early 
AVF failure occurred more often in females (60.8%) than 
in males (39.2%, P , 0.05).
Complications were observed in 44 patients (11.4%). 
Specifically, early thrombosis was seen in 23 patients and 
complications of the surgical area occurred in 21 patients. 
Five patients had hyperemia at the incision site, four 
Table 1 Patient demographics
Parameters n %
Patients/fistulae created 384/411
First AVF creation 320 83.3
Male 225 58.5
Female 159 41.5
Diabetes 234 60.9
Hypertension 184 47.9
Abbreviation: AVF, arteriovenous fistula.Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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had infection at the incision site, seven had hematoma at 
the incision site, five had revisions due to hemorrhage. 
Regression of hyperemia and infection was achieved by 
standard antibiotic therapy, and re-exploration was performed 
for hematoma. There were no early venous hypertension or 
vascular steal occurrences associated with brachiocephalic 
or brachiobasilic AVF formation (Table 3). The patients 
embarked on dialysis approximately 4.7 ± 1.8 weeks after 
the AVFs were created.
Discussion
In this study, we investigated the early patency rate for 
AVFs created in end-stage renal failure patients, factors 
affecting patency, and postoperative complications. AVFs 
are created internally or with grafts for hemodialysis, which 
is a treatment option for end-stage renal failure patients. 
Although there are many methods for creating an AVF, 
the most commonly preferred are the Brescia–Cimino and 
snuffbox methods. When distal access attempts fail for a 
variety reasons, repeat surgery can be undertaken to create 
new AVFs, and a brachiocephalic or brachiobasilic AVF can 
be created on the forearm.
Because there are various reasons for failure, it is appro-
priate to examine AVF patency rates in two groups, ie, early 
failures and late failures. Reasons for early failure include 
use of ill-suited veins, severe dehydration, obstruction of the 
outlet, a poor anastomosis, a vein kink near the anastomosis, 
and compression of a hematoma.11,12 Reasons for late failure 
include stenosis of the anastomosis line during and after 
development of intimal hyperplasia, fibrous tissue develop-
ment on the vein walls due to needle puncture trauma, and 
calcium phosphate deposition on the anastomosis line.13
A wide range of early failure rates have been reported in 
the literature. Da Silva et al14 reported a 15% early failure rate, 
Baldrati et al 13.5%,15 Sozudogru et al 18%,16 and Ozköleli 
et al 18.8%.17 Early failure rates in the range of 12%–29% have 
been observed in other studies.6,18,19 In a study that evaluated 
169 AVFs created in 122 patients, early patency was found to 
be 73.6% (early failure 26.4%), which decreased to 64.6% in 
the long-term, emphasizing that the early period is important 
for fistula patency.20 Also, Ekici et al21 reported a 12% 
early thrombosis rate. Fitzgerald et al22 reported that 2% of 
early thrombosis occurred after first use of the AVF. This study 
found an early thrombosis rate (5.98%) lower than that 
reported in the literature. This lower early thrombosis rate is 
attributed to the use of mechanical dilatation with a probe for 
spasm of both the arteries and veins, and to the use of topical 
papaverine. Hence, a proportion of early failure can be attrib-
uted to technical inadequacy, which can be avoided.
In a study by Miller et al,23 the success rate of AVFs 
on the forearm was reported to be lower in women than in 
men. Gibbons24 also reported lower patency rates in women. 
However, there are also studies that did not show a gender 
difference. Baser et al25 created 132 AVFs on 114 patients 
and did not find a gender difference in either early or late 
failure or in patency rates. Another study also found no 
difference in AVF patency rates between women and men.21 
The present study was consistent with the presence of a 
gender difference, finding early failure rates of 60.8% for 
women and of 39.2% for men.
In the early period following AVF formation, there may 
be a need for hospitalization or surgical revision due to local 
complications, such as thrombosis, hematoma, hemorrhage, 
or infection.26–29 The most common complication, early and 
late, is thrombosis of the fistula (3.0%–14.5%).28,30 In the 
present study, complications other than early thrombosis, 
such as revisions due to hyperemia, hematoma, infection, 
and hemorrhage at the incision site, were also occasionally 
observed. Although Horimi et al31 reported that AVF patency 
rates were significantly lower for diabetic patients, both 
Table 3 Types of AVF created and postoperative complications
AVF types n %
snuffbox 106 25.8
Brescia–cimino 264 64.3
Brachiocephalic 29 7.00
Brachiobasilic 12 2.91
Complications
early thrombosis 23 5.98
Hyperemia of incision site 5 1.30
Infection of incision site 4 1.04
Hematoma on incision site 7 1.82
Revision due to hemorrhage 3 0.78
Fistula not maturing 2 0.52
Abbreviation: AVF, arteriovenous fistula.
Table 2 causes of chronic renal failure in dialyzed patients
Disease n %
Polycystic renal disease 37 9.63
nephroangiosclerosis 25 6.51
glomerulonephritis 111 28.9
chronic pyelonephritis 57 14.84
Diabetes 29 7.55
Hypertension 11 2.86
Renal amyloidosis (primary or secondary) 4 1.04
Urological disease (stones, obstruction) 3 0.78
Other 25 6.51
Unknown 82 21.35Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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Wolowczyk et al30 and Ekici et al21 found that diabetes had no 
effect on AVF patency rates. Field et al32 reported that fistula 
survival rates in nondiabetic patients were higher than in 
patients with diabetes, but this difference was not significant. 
However, Erkut et al33 also reported that diabetes mellitus was 
one of the factors affecting the primary patency of AVF. No 
relationship was found between diabetes and fistula patency 
rate in this study.
Given that only 11% of end-stage renal failure patients 
undergo renal transplantation,34 and that the rest need regular 
and effective hemodialysis to maintain their lives at a certain 
level of quality, maximum care should be taken during the 
preoperative evaluation of the AVF created, as well as with 
the surgical technique.
Conclusion
In this study, the early fistula patency rate was better that in 
prior reports, and there are two possible explanations for this. 
Firstly, preoperative evaluation of the patients was performed 
very carefully, enabling the most appropriate site for AVF 
to be determined. Secondly, careful consideration was given 
to the anastomosis technique, which included mechanical 
dilatation and a vasodilatory agent for both the artery and 
vein in each patient. Mechanical dilatation of the artery and 
vein, before starting the anastomosis, as well as the use of a 
vasodilatory agent can decrease the risk of early thrombosis 
of the fistula. Although the high patency rate of the AVFs in 
this study may be due to this intervention, further randomized 
studies comparing mechanical dilatation and papaverine with 
mechanical dilatation and/or placebo are warranted to define 
the exact role of these interventions.
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